Published in Br J Pharmacol on March 01, 1993
Roles of M2 and M3 muscarinic receptors in cholinergic nerve-induced contractions in mouse ileum studied with receptor knockout mice. Br J Pharmacol (2006) 0.95
Mechanism of bradykinin-induced plasma extravasation in the rat knee joint. Br J Pharmacol (1995) 0.92
Delayed-type hypersensitivity-induced increase in vascular permeability in the mouse small intestine: inhibition by depletion of sensory neuropeptides and NK1 receptor blockade. Br J Pharmacol (1995) 0.90
Chronic restraint stress inhibits hair growth via substance P mediated by reactive oxygen species in mice. PLoS One (2013) 0.87
The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist. Br J Pharmacol (1995) 0.84
Characterization of central and peripheral effects of septide with the use of five tachykinin NK1 receptor antagonists in the rat. Br J Pharmacol (1999) 0.81
Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B. Br J Pharmacol (1995) 0.79
Inhibition of Ca(2+)-sensitive K+ currents in NG 108-15 cells by substance P and related tachykinins. Br J Pharmacol (1996) 0.78
Blockade of neurokinin-1 receptors in the ventral respiratory column does not affect breathing but alters neurochemical release. J Appl Physiol (1985) (2015) 0.77
Contractile effect of tachykinins on rabbit small intestine. Acta Pharmacol Sin (2011) 0.76
Substance P in the anterior thalamic paraventricular nucleus: promotion of ethanol drinking in response to orexin from the hypothalamus. Addict Biol (2015) 0.75
Mechanical Conflict System: A Novel Operant Method for the Assessment of Nociceptive Behavior. PLoS One (2016) 0.75
A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem (1985) 90.20
Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem J (1982) 8.16
A potent nonpeptide antagonist of the substance P (NK1) receptor. Science (1991) 4.06
Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proc Natl Acad Sci U S A (1991) 2.30
Species differences in affinities of non-peptide antagonists for substance P receptors. Eur J Pharmacol (1991) 1.95
Mammalian tachykinin receptors. Annu Rev Neurosci (1991) 1.78
Tachykinins. Annu Rev Neurosci (1988) 1.58
Biological evaluation of substance P antagonists. Br J Pharmacol (1984) 1.39
Possible existence of a new tachykinin receptor subtype in the guinea pig ileum. Peptides (1992) 1.21
Activity and distribution of binding sites in brain of a nonpeptide substance P (NK1) receptor antagonist. Science (1991) 1.17
Potent and highly selective neurokinin antagonists. J Med Chem (1990) 1.13
Receptors for substance P and related neurokinins. Pharmacology (1989) 1.11
Selectivity and specificity of new, non-peptide, quinuclidine antagonists of substance P. Biochem Biophys Res Commun (1991) 1.10
Molecular cloning, structural characterization and functional expression of the human substance P receptor. Biochem Biophys Res Commun (1991) 1.10
Effects of tachykinins on inositol phospholipid hydrolysis in slices of hamster urinary bladder. Br J Pharmacol (1987) 1.08
The human neurokinin A (substance K) receptor. Molecular cloning of the gene, chromosome localization, and isolation of cDNA from tracheal and gastric tissues. J Biol Chem (1990) 1.08
Inhibition of tachykinin-induced hypotension in dogs by CP-96,345, a selective blocker of NK-1 receptors. Naunyn Schmiedebergs Arch Pharmacol (1991) 1.07
A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivative. Mol Pharmacol (1984) 1.04
Neuropeptide K: isolation, structure and biological activities of a novel brain tachykinin. Biochem Biophys Res Commun (1985) 1.02
Analysis of tachykinin binding site interactions using constrained analogues of tachykinins. Biochem Pharmacol (1988) 0.93
Effect of CP-96,345, a nonpeptide substance P receptor antagonist, on salivation in rats. Proc Natl Acad Sci U S A (1991) 0.92
3H-neurokinin A labels a specific tachykinin-binding site in the rat duodenal smooth muscle. Mol Pharmacol (1987) 0.92
Neuropeptide-gamma: a peptide isolated from rabbit intestine that is derived from gamma-preprotachykinin. J Neurochem (1988) 0.91
Neuropeptide K, scyliorhinin I and II: new tools in the tachykinin receptor field. Eur J Pharmacol (1988) 0.89
Tachykinin receptors of the NK1 type (substance P) coupled positively to phospholipase C on cortical astrocytes from the newborn mouse in primary culture. J Neurochem (1989) 0.87
Specific binding of a 125I-substance P derivative to rat brain synaptosomes. J Neurochem (1983) 0.86
Immunohistochemical and behavioral analysis of spinal lesions induced by a substance P antagonist and protection by thyrotropin releasing hormone. Exp Brain Res (1989) 0.85
Specific recognition of SP or NKB receptors by analogues of SP substituted at positions 8 and 9. Eur J Pharmacol (1986) 0.84
Immunohistochemical evidence for a "neurotoxic" action of (D-Pro2, D-Trp7,9)-substance P, an analogue with substance P antagonistic activity. Acta Physiol Scand (1981) 0.84
The human neurokinin A (substance K) receptor. Molecular cloning of the gene, chromosome localization, and isolation of the cDNA from tracheal and gastric tissues. J Biol Chem (1991) 0.83
NK-1 receptors are the only class of tachykinin receptors found on mouse cortical astrocytes. Peptides (1992) 0.82
Further demonstration that [Pro9]-substance P is a potent and selective ligand of NK-1 tachykinin receptors. J Neurochem (1991) 0.81
Synergistic regulation of cytosolic Ca2+ concentration in mouse astrocytes by NK1 tachykinin and adenosine agonists. J Neurochem (1991) 0.80
Molecular biological studies on the diversity of chemical signalling in tachykinin peptidergic neurons. Ann N Y Acad Sci (1990) 0.80
Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem (1966) 7.91
Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science (1999) 4.31
Hippocampo-prefrontal cortex pathway: anatomical and electrophysiological characteristics. Hippocampus (2000) 2.18
Spinal tuberculosis in adults. A study of 103 cases in a developed country, 1980-1994. Medicine (Baltimore) (1999) 2.11
The physiologic disposition and metabolism of norepinephrine in immunosympathectomized animals. J Pharmacol Exp Ther (1966) 2.03
Reduced uptake of tritiated noradrenaline in tissues of immunosympathectomized animals. Nature (1965) 1.91
Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes. Nature (1995) 1.83
Dopaminergic terminals in the rat cortex. Science (1973) 1.73
Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J Neurosci (1997) 1.66
G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptor with adenylyl cyclase. J Neurosci (1993) 1.66
Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature (1983) 1.66
Mechanism involved in initiation and propagation of receptor-induced intercellular calcium signaling in cultured rat astrocytes. J Neurosci (1997) 1.62
Dendritic release of dopamine in the substantia nigra. Nature (1981) 1.58
Uptake, storage and metabolism of norepinephrine in tissues of the developing rat. J Pharmacol Exp Ther (1967) 1.58
Selective activation of mesocortical DA system by stress. Nature (1976) 1.56
Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosis. J Neurosci (1999) 1.52
Astrocytes protect neurons from hydrogen peroxide toxicity. J Neurosci (1996) 1.51
Nicotine protects cultured striatal neurones against N-methyl-D-aspartate receptor-mediated neurotoxicity. Neuroreport (1994) 1.46
Stimulation of dopamine release by GABA in rat striatal slices. Brain Res (1978) 1.45
Effect of noxious tail pinch on the discharge rate of mesocortical and mesolimbic dopamine neurons: selective activation of the mesocortical system. Brain Res (1989) 1.45
Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine. J Neurosci (1998) 1.44
Characterization of PEA-15, a major substrate for protein kinase C in astrocytes. J Biol Chem (1993) 1.43
Gap junctions in cultured astrocytes: single-channel currents and characterization of channel-forming protein. Neuron (1991) 1.40
Inhibition by hemicholinium-3 of (14C)acetylcholine synthesis and (3H)choline high-affinity uptake in rat striatal synaptosomes. Mol Pharmacol (1973) 1.36
Relationships between the prefrontal cortex and the basal ganglia in the rat: physiology of the corticosubthalamic circuits. J Neurosci (1998) 1.36
Effects of stress on the metabolism of norepinephrine, dopamine and serotonin in the central nervous system of the rat. I. Modifications of norepinephrine turnover. J Pharmacol Exp Ther (1968) 1.33
Selectivity of the hippocampal projection to the prelimbic area of the prefrontal cortex in the rat. Brain Res (1989) 1.32
The uptake and storage of H3-norepinephrine in the reserpine-pretreated rat heart. J Pharmacol Exp Ther (1965) 1.30
Anatomical and electrophysiological evidence for a direct projection from Ammon's horn to the medial prefrontal cortex in the rat. Exp Brain Res (1987) 1.29
Some evidence for the existence of dopaminergic neurons in the rat cortex. Brain Res (1973) 1.26
Regional studies of catecholamines in the rat brain. II. Rate of turnover of catecholamines in various brain regions. J Neurochem (1966) 1.23
A sustained effect of electroconvulsive shock on the turnover of norepinephrine in the central nervous system of the rat. Proc Natl Acad Sci U S A (1967) 1.23
Inhibitory influence of the mesocortical dopaminergic system on spontaneous activity or excitatory response induced from the thalamic mediodorsal nucleus in the rat medial prefrontal cortex. Brain Res (1984) 1.23
Possible existence of a new tachykinin receptor subtype in the guinea pig ileum. Peptides (1992) 1.21
Glial heterogeneity may define the three-dimensional shape of mouse mesencephalic dopaminergic neurones. Nature (1984) 1.20
Glutamate-dependent phosphorylation of elongation factor-2 and inhibition of protein synthesis in neurons. J Neurosci (1997) 1.19
Differential effects of ascending neurons containing dopamine and noradrenaline in the control of spontaneous activity and of evoked responses in the rat prefrontal cortex. Neuroscience (1988) 1.19
Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat. Nat New Biol (1973) 1.19
Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of H3-norepinephrine and H3-dopamine. J Pharmacol Exp Ther (1966) 1.18
Selective activation of the mesocortico-frontal dopaminergic neurons induced by lesion of the habenula in the rat. Brain Res (1980) 1.16
Cellular expression, developmental regulation, and phylogenic conservation of PEA-15, the astrocytic major phosphoprotein and protein kinase C substrate. J Neurochem (1995) 1.13
Nicotinic effect of acetylcholine on the release of newly synthesized (3H)dopamine in rat striatal slices and cat caudate nucleus. Brain Res (1976) 1.13
Endothelin induces a calcium-dependent phosphorylation of PEA-15 in intact astrocytes: identification of Ser104 and Ser116 phosphorylated, respectively, by protein kinase C and calcium/calmodulin kinase II in vitro. J Neurochem (1998) 1.13
Relationship between the locomotor hyperactivity induced by A10 lesions and the destruction of the fronto-cortical dopaminergic innervation in the rat. Brain Res (1978) 1.13
Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat. Mol Pharmacol (1978) 1.11
Segregation and convergence of information flow through the cortico-subthalamic pathways. J Neurosci (2001) 1.11
Effect of striatal cells on in vitro maturation of mesencephalic dopaminergic neurones grown in serum-free conditions. Nature (1980) 1.09
Activity-dependent neuronal control of gap-junctional communication in astrocytes. J Cell Biol (2000) 1.09
Inhibitory effects of ventral tegmental area stimulation on the activity of prefrontal cortical neurons: evidence for the involvement of both dopaminergic and GABAergic components. Neuroscience (1992) 1.09
Blockade of prefronto-cortical alpha 1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection. Eur J Neurosci (1994) 1.08
Involvement of cholinergic presynaptic receptors of nicotinic and muscarinic types in the control of the spontaneous release of dopamine from striatal dopaminergic terminals in the rat. J Pharmacol Exp Ther (1977) 1.08
Dopamine-norepinephrine: another regulatory step of norepinephrine synthesis in central noradrenergic neurons. Eur J Pharmacol (1971) 1.07
Acetylcholine synthesis from (2- 14 C)pyruvate in rat striatal slices. J Neurochem (1973) 1.06
Inhibition of dopamine release in the cat caudate nucleus by nigral application of glycine. Eur J Pharmacol (1978) 1.05
In vitro maturation of mesencephalic dopaminergic neurons from mouse embryos is enhanced in presence of their striatal target cells. Proc Natl Acad Sci U S A (1979) 1.05
A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivative. Mol Pharmacol (1984) 1.04
Effects of drugs on the disposition of H-3-norepinephrine in the rat brain. Pharmacol Rev (1966) 1.04
Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J Neurochem (1991) 1.04
Increase in external glutamate and NMDA receptor activation contribute to H2O2-induced neuronal apoptosis. J Neurochem (1999) 1.02
Release of newly synthesized dopamine from dopamine-containing terminals in the striatum of the rat. Proc Natl Acad Sci U S A (1969) 1.02
[Epidemiological aspects of osteoarticular tuberculosis in adults. Retrospective study of 206 cases diagnosed in the Paris area from 1980 to 1994]. Presse Med (1997) 1.02
The role of presynaptic receptors in the release and synthesis of 3H-dopamine by slices of rat striatum. Naunyn Schmiedebergs Arch Pharmacol (1976) 1.02
Sphingosine-1-phosphate induces proliferation of astrocytes: regulation by intracellular signalling cascades. Eur J Neurosci (2001) 1.01
Regional studies of catecholamines in the rat brain. 3. Subcellullar distribution of endogenous and exogenous catecholamines in various brain regions. Biochem Pharmacol (1966) 1.01
Relationships between the prefrontal cortex and the basal ganglia in the rat: physiology of the cortico-nigral circuits. J Neurosci (1999) 1.01
Increase in rat brain tyrosine hydroxylase activity produced by electroconvulsive shock. Proc Natl Acad Sci U S A (1969) 1.00
Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo. Neurosci Lett (1992) 1.00
An abundant mRNA of the embryonic brain persists at a high level in cerebellum, hippocampus and olfactory bulb during adulthood. Eur J Neurosci (1993) 1.00
Metabolism of norepinephrine in the central nervous system. Pharmacol Rev (1966) 1.00
Dynamic characteristic of the 'functional compartment' of dopamine in dopaminergic terminals of the rat striatum. J Neurochem (1971) 1.00
Gap junctional communication and pharmacological heterogeneity in astrocytes cultured from the rat striatum. J Physiol (1998) 0.99
Release of dopamine in both caudate nuclei and both substantia nigrae in response to unilateral stimulation of cerebellar nuclei in the cat. Brain Res (1978) 0.97
[3H]neurokinin B and 125I-Bolton Hunter eledoisin label identical tachykinin binding sites in the rat brain. J Neurochem (1987) 0.97
Release of dopamine evoked by electrical stimulation of the motor and visual areas of the cerebral cortex in both caudate nuclei and in the substantia nigra in the cat. Brain Res (1978) 0.97
Inhibitory influence of the nigrostriatal dopamine system on the striatal cholinergic neurons in the rat. Brain Res (1975) 0.96
Adrenergic regulation of intercellular communications between cultured striatal astrocytes from the mouse. Proc Natl Acad Sci U S A (1991) 0.96
The major astrocytic phosphoprotein PEA-15 is encoded by two mRNAs conserved on their full length in mouse and human. J Biol Chem (1996) 0.96
Endothelins regulate astrocyte gap junctions in rat hippocampal slices. Eur J Neurosci (2004) 0.96
Dopamine uptake in serotoninergic terminals in vitro: a valuable tool for the histochemical differentiation of catecholaminergic and serotoninergic terminals in rat cerebral structures. Brain Res (1978) 0.96
Release of dopamine in vivo from cat substantia nigra. Nature (1977) 0.95
Spatial organization of patch and matrix compartments in the rat striatum. Neuroscience (1993) 0.95
Ontogenesis of neostriatal cholinergic neurones in the rat and development of their sensitivity to neuroleptic drugs. Naunyn Schmiedebergs Arch Pharmacol (1975) 0.95
Increased synthesis and release of dopamine in the striatum of the rat after amantadine treatment. Eur J Pharmacol (1970) 0.95
A neuroglial cooperativity is required for the potentiation by 2-chloroadenosine of the muscarinic-sensitive phospholipase C in the striatum. J Neurosci (1989) 0.94
Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice. Brain Res (1998) 0.94
Storage and synthesis of norepinephrine in the reserpine-treated rat brain. J Pharmacol Exp Ther (1966) 0.94
Distinct presynaptic control of dopamine release in striosomal and matrix areas of the cat caudate nucleus. Proc Natl Acad Sci U S A (1989) 0.94
L-glutamate-evoked release of dopamine from synaptosomes of the rat striatum: involvement of AMPA and N-methyl-D-aspartate receptors. Neuroscience (1992) 0.93
Injection of 6-hydroxydopamine in the substantia nigra of the rat. I. Morphological study. Brain Res (1973) 0.93
Analysis of tachykinin binding site interactions using constrained analogues of tachykinins. Biochem Pharmacol (1988) 0.93
Effect of sodium, hemicholinium-3 and antiparkinson drugs on (14C)acetylcholine synthesis and (3H)choline uptake in rat striatal synaptosomes. Brain Res (1973) 0.93
Prefrontal cortex inputs of the nucleus accumbens-nigro-thalamic circuit. Neuroscience (1996) 0.93
Plasma tryptophan and 5-HT metabolism in the CNS of the newborn rat. J Neurochem (1974) 0.93
Retrograde axonal transport of 125I-tetanus toxin as a tool for tracing fiber connections in the central nervous system; connections of the rostral part of the rat neostriatum. Brain Res (1977) 0.93
The nonpeptide NK-2 antagonist SR 48968 is also a NK-3 antagonist in the guinea but not in the rat. Biochem Biophys Res Commun (1993) 0.92